Biomea Fusion, Inc. (BMEA)
1.42
+0.05
(+3.65%)
USD |
NASDAQ |
Oct 09, 16:00
1.415
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Free Cash Flow (Quarterly) : -10.03M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.03M |
| March 31, 2026 | -11.67M |
| December 31, 2025 | -13.19M |
| September 30, 2025 | -12.18M |
| June 30, 2025 | -19.33M |
| March 31, 2025 | -25.67M |
| December 31, 2024 | -30.09M |
| September 30, 2024 | -25.40M |
| June 30, 2024 | -32.70M |
| March 31, 2024 | -32.06M |
| December 31, 2023 | -22.84M |
| September 30, 2023 | -23.94M |
| June 30, 2023 | -26.23M |
| Date | Value |
|---|---|
| March 31, 2023 | -26.95M |
| December 31, 2022 | -20.91M |
| September 30, 2022 | -16.74M |
| June 30, 2022 | -15.70M |
| March 31, 2022 | -10.09M |
| December 31, 2021 | -16.19M |
| September 30, 2021 | -11.03M |
| June 30, 2021 | -7.247M |
| March 31, 2021 | -4.142M |
| December 31, 2020 | -2.775M |
| September 30, 2020 | -1.114M |
| June 30, 2020 | -0.369M |
| March 31, 2020 | -0.252M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| REGENXBIO, Inc. | -63.00M |
| Compass Therapeutics, Inc. | -14.91M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Alnylam Pharmaceuticals, Inc. | 292.04M |
| Anika Therapeutics, Inc. | -2.133M |